- Home
- GLV vs EDAP Comparison
GLV vs EDAP Comparison
Compare GLV & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLV
- EDAP
- Stock Information
- Founded
- GLV 2004
- EDAP 1979
- Country
- GLV United States
- EDAP France
- Employees
- GLV N/A
- EDAP N/A
- Industry
- GLV Finance/Investors Services
- EDAP Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- GLV Finance
- EDAP Health Care
- Exchange
- GLV Nasdaq
- EDAP Nasdaq
- Market Cap
- GLV 72.1M
- EDAP 81.6M
- IPO Year
- GLV N/A
- EDAP 1997
- Fundamental
- Price
- GLV $5.52
- EDAP $2.58
- Analyst Decision
- GLV
- EDAP Strong Buy
- Analyst Count
- GLV 0
- EDAP 1
- Target Price
- GLV N/A
- EDAP $19.00
- AVG Volume (30 Days)
- GLV 54.2K
- EDAP 42.8K
- Earning Date
- GLV 01-01-0001
- EDAP 03-26-2025
- Dividend Yield
- GLV 12.44%
- EDAP N/A
- EPS Growth
- GLV N/A
- EDAP N/A
- EPS
- GLV N/A
- EDAP N/A
- Revenue
- GLV N/A
- EDAP $70,722,730.00
- Revenue This Year
- GLV N/A
- EDAP $6.96
- Revenue Next Year
- GLV N/A
- EDAP $15.53
- P/E Ratio
- GLV N/A
- EDAP N/A
- Revenue Growth
- GLV N/A
- EDAP 12.17
- 52 Week Low
- GLV $4.70
- EDAP $2.00
- 52 Week High
- GLV $6.06
- EDAP $8.50
- Technical
- Relative Strength Index (RSI)
- GLV 49.97
- EDAP 54.13
- Support Level
- GLV $5.51
- EDAP $2.46
- Resistance Level
- GLV $5.60
- EDAP $2.69
- Average True Range (ATR)
- GLV 0.06
- EDAP 0.14
- MACD
- GLV 0.00
- EDAP 0.01
- Stochastic Oscillator
- GLV 65.62
- EDAP 48.39
About GLV Clough Global Dividend and Income Fund of beneficial interest
Clough Global Dividend and Income Fund is a closed-ended investment management company. The fund's investment objective is to provide a high level of total return. It invests in equity and debt securities in both U.S. and non-U.S. markets of companies of any market capitalization.
About EDAP EDAP TMS S.A.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its global activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.